John M D Storey

Title: John M D Storey: Innovator in Tauopathy Treatment

Introduction

John M D Storey is a notable inventor based in Ross-shire, GB. He has made significant contributions to the field of chemical synthesis and purification, particularly in the treatment of tauopathy conditions. His innovative work has led to the development of methods that utilize thioninium compounds for medical applications.

Latest Patents

John M D Storey holds a patent for "Methods of treatment of a tauopathy condition comprising the use of thioninium compounds." This invention focuses on synthesizing and purifying specific 3,7-diaminophenothiazin-5-ium compounds, including Methythioninium Chloride (MTC), commonly known as Methylene Blue. The patent outlines a detailed process that includes steps such as nitrosylation, oxidative coupling, and recrystallization, ultimately leading to high-purity compounds that can be used in various medical treatments.

Career Highlights

Storey is associated with Wista Laboratories Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments for conditions such as Alzheimer's disease, skin cancer, and various infectious diseases. His innovative methods have the potential to significantly impact the medical field.

Collaborations

John M D Storey has collaborated with esteemed colleagues, including Claude Michel Wischik and Janet Elizabeth Rickard. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

John M D Storey is a distinguished inventor whose work in tauopathy treatment exemplifies the intersection of chemical synthesis and medical innovation. His contributions are paving the way for new therapeutic options in the fight against debilitating diseases.